Canada markets closed
LATEST UPDATE

NO WEEKLY BRIEF NEWSLETTER FOR THE WEEKEND OF OCT. 16-17

We are taking a short break, but we will be back next week. Stay tuned!

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.49-0.41 (-1.52%)
At close: 4:00PM EDT
26.49 0.00 (0.00%)
After hours: 04:02PM EDT

Insmed Incorporated

700 US Highway 202/206
Bridgewater, NJ 08807-1704
United States
908 977 9900
http://www.insmed.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees521

Key Executives

NameTitlePayExercisedYear Born
Mr. William H. Lewis J.D., M.B.A.Pres, CEO & Chairman1.19M8.49M1969
Ms. Sara M. Bonstein MBAChief Financial Officer697.72kN/A1981
Mr. Roger AdsettChief Operating Officer793.9kN/A1969
Mr. John Goll IIISr. VP & Chief Accounting Officer513.37k831.68kN/A
Ms. Christine A. Pellizzari J.D.Consultant732.85k3.96M1968
Dr. Martina Flammer M.B.A., M.D.Chief Medical Officer934.41kN/A1964
Eleanor BarisserAssociate Director of Investor RelationsN/AN/AN/A
Mr. John D. Soriano J.D.Chief Compliance OfficerN/AN/A1962
Mr. Michael Alexander SmithSr. VP & Gen. CounselN/AN/A1977
Mandy FaheySr. Director of Corp. CommunicationsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Corporate Governance

Insmed Incorporated’s ISS Governance QualityScore as of September 26, 2021 is 6. The pillar scores are Audit: 3; Board: 4; Shareholder Rights: 9; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.